The Humane Research Trust’s Post

𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐃𝐫𝐮𝐠 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭: 𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://lnkd.in/dEFgT2Hw Here are the Key Drivers of Transforming Drug Development: 1. Advanced Data Analytics & AI 2. The Role of Synthetic Biology 3. Personalized Medicine 4. Regulatory Innovations #SyntheticBiology #DrugDevelopment #PharmaInnovation #BiotechRevolution #PrecisionMedicine

Transform the 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐰𝐢𝐭𝐡 𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬! From 𝐢𝐝𝐞𝐧𝐭𝐢𝐟𝐲𝐢𝐧𝐠 𝐝𝐢𝐬𝐞𝐚𝐬𝐞-related genes to designing 𝐬𝐚𝐟𝐞 𝐚𝐧𝐝 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 drug molecules, bioinformatics is revolutionizing healthcare. 𝐓𝐡𝐢𝐬 𝐟𝐢𝐞𝐥𝐝 𝐞𝐦𝐩𝐨𝐰𝐞𝐫𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐭𝐨: -Identify disease-related genes for precise treatments. -Screen millions of compounds for potential drug candidates. -Design personalized medicine tailored to individual needs. 𝐓𝐚𝐤𝐞 𝐲𝐨𝐮𝐫 𝐟𝐢𝐫𝐬𝐭 𝐬𝐭𝐞𝐩 towards 𝐦𝐚𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 and shaping the future of 𝐝𝐫𝐮𝐠 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲. Join 𝐨𝐮𝐫 𝐜𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐜𝐨𝐮𝐫𝐬𝐞 and become a vital part of this transformative journey. 📞 +91-9148711600 🌐 clinilaunchresearch.in #Bioinformatics #drugdiscovery #PersonalizedMedicine #FutureOfMedicine #HealthcareInnovation #clinicalresearch #genomics #lifesciences #MedicalBreakthroughs #clinilaunch #trendingreelsvideo #trendingtopic

⚙️ Demystifying machine learning in drug development Quin Wills, our CSO and co-founder, recently spoke to The Medicine Maker about how we navigate the intricate relationship between machine learning and the quest for quicker, more effective drug development: 🔹Generating quality, human-centric data in R&D 🔹 Utilising human cells, tissues, and organs to build more accurate disease models 🔹 Leveraging machine learning to refine drug discovery processes and embrace the complexity of human biology. It's important we balance the investment in data innovation between data production, cleaning,and application to overcome the current limitations in liver disease treatment development. Read the full article ⬇️ https://lnkd.in/gsUWgNJX #TeamOchre #biotech #genomics #LiverDisease

🔬 BD rolls out new robotics-compatible solution for single-cell research BD said the first in a series of high-throughput reagent kits are designed to bring consistency and enhance efficiency to the large-scale analysis of genetic material. The collaboration between BD and Hamilton created an automated solution that standardises traditionally manual processes and speeds the generation of material for genetic sequencing. The solution comprises the BD OMICS-One XT WTA Assay and the Hamilton Microlab NGS STAR automated liquid-handling platform. Read more online: https://lnkd.in/e4jjYGSb 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

🚨 New Frontiers in Preclinical Testing! Scientific poster with Astra Zenaca🚨 How can we reliably predict inflammatory reactions in response to subcutaneously injected drugs before they reach clinical trials? The answer lies in the HypoSkin® model, an ethical, human-based alternative to traditional animal testing. 📌 HypoSkin® uses fully human skin models to evaluate local inflammatory responses, capturing: Normal subcutaneous tissue architecture. Inflammatory singnature upon injection. Key cytokine markers over time. Learn how this technology enhances the predictability of drug safety testing while supporting ethical science. 🌱 👉🏻https://bit.ly/3YAHn99

🚨 New Frontiers in Preclinical Testing! Scientific poster with Astra Zenaca🚨 How can we reliably predict inflammatory reactions in response to subcutaneously injected drugs before they reach clinical trials? The answer lies in the HypoSkin® model, an ethical, human-based alternative to traditional animal testing. 📌 HypoSkin® uses fully human skin models to evaluate local inflammatory responses, capturing: Normal subcutaneous tissue architecture. Inflammatory singnature upon injection. Key cytokine markers over time. Learn how this technology enhances the predictability of drug safety testing while supporting ethical science. 🌱 👉🏻https://bit.ly/48ARlMk

We are witnessing a profound transformation in drug discovery thanks to the integration of unified storage solutions in genomics research. These cutting-edge systems are reshaping how data is managed, offering a centralized, streamlined approach that enhances efficiency and precision in research endeavors. Our latest video delves into the pivotal role of unified storage solutions in revolutionizing genomics research and expeditiously propelling the drug discovery process forward: https://bit.ly/48J10Pu

We've got LOTS of exciting news coming down the pipe for Ignota Labs I think (correctly) the first is an opportunity to learn more about the Ignota Labs SAFEPATH platform. ☠️ Toxicity remains one of the greatest challenges in drug development—causing late-stage failures, spiralling costs, and patient safety risks. At Ignota Labs, we believe this challenge can be overcome with the right tools and insights. That’s why we created SAFEPATH, an AI-driven platform designed to uncover why toxicities occur and how to mitigate them. By integrating cheminformatics, bioinformatics, and explainable AI, SAFEPATH transforms raw data into actionable solutions for safer, more effective drug development. 📥 Get the full story: Our new white paper dives into: • The cutting-edge SAFEPATH framework and how it works. • Case studies, including how SAFEPATH identified previously unknown mechanisms of toxicity in cancer therapies. • How SAFEPATH can rescue failing compounds and accelerate safer drugs to market. 👉 Download the white paper today to learn how SAFEPATH is reshaping drug safety: https://lnkd.in/eYWVRMnS #DrugDevelopment #AIinPharma #DrugSafety #SAFEPATH #PharmaInnovation #WhitePaper

What are some key ingredients to consider for pharmacological modeling in the age of artificial intelligence? In a recent webinar, James Lu, Distinguished AI Scientist in Modeling & Simulation/Clinical Pharmacology at Genentech, had three recommendations: - Extend our modeling language - Generalize familiar concepts - Augment our intelligence Learn what he had in mind—you can now watch this webinar on-demand: https://lnkd.in/gejDBVYv

Angeline Lim, Ph.D., our Senior Applications Scientist, specializes in high-content imaging and analysis. She works predominately in developing automated 3D biology workflows and leverages AI to derive actionable readouts from complex phenotypic assays. (Among many, other, science things! Outside of the lab, she’s a pro at raising cute little chickens 🐤 in her backyard for home-grown eggs. Just ask her.) Check out her latest published perspectives: https://ow.ly/mqR950SGcC0. 🤖 AI Takes On Drug Discovery: https://lnkd.in/gjnWUZTN #3dbiology #3dcellculture #organoids #drugdiscovery #drugscreening #drugdevelopment #diseasemodeling #labautomation #ai #machinelearning #deeplearning #highcontentimaging #highcontentscreening #scienceandtechnology #pharma #geneeditting #cellculture #pdo #imageanalysis #IntheNews